Triventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Descope is a no/low-code customer identity and access management (CIAM) platform that lets developers build authentication and user journeys using a drag-and-drop visual editor, SDKs, or REST APIs.
CybersecurityDeveloper ToolsSaaSLos Altos, US
Slavik Markovich(Founder)inGilad Shriki(Founder)inDan Sarel(Founder)inDoron Sharon(Founder)inGuy Rinat(Founder)inMeir Wahnon(Founder)in
Co-investorsDell Technologies CapitalJ-VenturesLightspeed Venture PartnersNotable CapitalUnusual VenturesVerissimo Ventures+2 more
FemSelect develops EnPlace, an FDA-cleared, minimally invasive same-day treatment for Pelvic Organ Prolapse in women.
Digital HealthFemTechMedical Devices
Sasha Schrodein
Co-investorsMEDA AngelsRobin Hood VenturesTransPacific Venture PartnersNew Age Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













